Skip to content
healthcare.dev

LACOSAMIDE

NDC 51991-348, LACOSAMIDE, tablet, film coated, from Breckenridge Pharmaceutical, Inc..

Product NDC
51991-348
Status
Listed
Labeler
Breckenridge Pharmaceutical, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204921
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51991-348 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE50 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
51991-348-0551991034805500 TABLET, FILM COATED in 1 BOTTLE (51991-348-05)
51991-348-065199103480660 TABLET, FILM COATED in 1 BOTTLE (51991-348-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f7ea3ce6-4ca7-4405-a011-48e7d71360a5
  • NADAC price for package 51991034805

    GET /v1/drugs/nadac/51991034805
  • NADAC price for package 51991034806

    GET /v1/drugs/nadac/51991034806

Use it

Look up 51991-348 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51991-348 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51991-348. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.